Cromos Pharma is at the BIO International Convention 2024
We are at the BIO International Convention 2024 Cromos Pharma’s US Business Development Director Nicole Brenna is currently attending the BIO Convention Conference 2024. She is actively representing our company, meeting with partners, and conducting strategic client meetings. We look forward to fostering new connections and exploring innovative opportunities in the industry. #BIOConvention2024 #CromosPharma
Cromos Pharma's Strategic Meeting in Warsaw
Cromos Pharma’s Strategic Meeting in Warsaw Last week, the Cromos Pharma Poland executive team gathered in Warsaw for a dynamic full-day meeting, marking a significant step in strengthening our internal connections and enhancing operational strategies. This gathering was not just a meeting but an opportunity for team members to forge stronger bonds and share insights. The agenda was packed with constructive
FDA approves first direct-to-consumer glucose monitor | Cromos Pharma
Revolutionizing Diabetes Management: FDA Approves First Direct-to-Consumer Glucose Monitor The FDA has given the green light to the Dexcom Stelo Glucose Biosensor System, the first of its kind continuous glucose monitor (CGM) that will be available directly to consumers. Slated for release in summer 2024, this innovative device offers adults over 18 who do not rely on insulin a novel way to monitor their

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us